Ptc Therapeutics (PTCT) Other financing activities (2013 - 2026)

Ptc Therapeutics' Other financing activities history runs 14 years deep, the most recent figure standing at $13.2 million for Q2 2026.

• In Q2 2026, Other financing activities rose 1067.02% year-over-year to $13.2 million; the TTM figure through Jun 2026 stood at $242.8 million (up 1535.02% YoY), while the FY2025 annual figure was $240.0 million, down 0.74% from the prior year.
• Other financing activities for Q2 2026 stood at $13.2 million, up from $6.4 million in the prior quarter.
• The five-year high for Other financing activities was $976.2 million in Q4 2023, with the low at -$2.0 million in Q3 2024.
• The 5-year median for Other financing activities is $10.0 million (2022), against an average of $91.3 million.
• The sharpest annual moves came in 2022 and 2024: Other financing activities jumped 2994.79% in 2022, then plunged 159.14% in 2024.
• Ptc Therapeutics' Other financing activities stood at $36.8 million in 2022, then jumped by 2553.01% to $976.2 million in 2023, then tumbled by 100.21% to -$2.0 million in 2024, then soared by 10221.93% to $206.3 million in 2025, then slumped by 93.58% to $13.2 million in 2026.
• Business Quant data shows PTCT's Other financing activities at $13.2 million in Q2 2026, $6.4 million in Q1 2026, and $206.3 million in Q4 2025.